Back
Biomarin Pharmaceutical Stock Price Chart
Google closes secret $20B deal with Apple to become iPhone's default search engine
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
68
BMRN
Biomarin Pharmaceutical
Last Price:
$71.51
Seasonality Move:
2.15%
7 Day Trial
ALL ACCESS PASS
$
7
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and BMRN is experiencing slight selling pressure.
Biomarin Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.27 | Buy |
| 20-day SMA: | 70.92 | Buy |
| 50-day SMA: | 66.82 | Buy |
| 200-day SMA: | 73.76 | Sell |
| 8-day EMA: | 71.36 | Buy |
| 20-day EMA: | 70.32 | Buy |
| 50-day EMA: | 68.42 | Buy |
| 200-day EMA: | 72.59 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.31 | Buy |
| Relative Strength Index (14 RSI): | 59.02 | Buy |
| Chaikin Money Flow: | -155324 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.94 - 72.12) | Buy |
| Bollinger Bands (100): | (63.45 - 69.33) | Buy |
Biomarin Pharmaceutical Technical Analysis
| Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
-
Biomarin Pharmaceutical share price is 71.53 while BMRN 8-day simple moving average is 71.27, which is a Buy signal.
-
The stock price of BMRN is 71.53 while Biomarin Pharmaceutical 20-day SMA is 70.92, which makes it a Buy.
-
Biomarin Pharmaceutical 50-day simple moving average is 66.82 while BMRN share price is 71.53, making it a Buy technically.
-
BMRN stock price is 71.53 and Biomarin Pharmaceutical 200-day simple moving average is 73.76, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Buy
68
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a BuyThe current Biomarin Pharmaceutical [BMRN] share price is $71.53. The Score for BMRN is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
13.6B
Price in USD:
71.53
Share Volume:
1.5M
Biomarin Pharmaceutical 52-Week Range
52-Week High:
94.85
52-Week Low:
60.63
Buy
68
Biomarin Pharmaceutical (BMRN)
is a Buy
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?The Biomarin Pharmaceutical stock price is 71.53 USD today.
-
Will BMRN stock go up or go down?Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators
-
Is Biomarin Pharmaceutical overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is not overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
-
Biomarin Pharmaceutical share price is 71.53 while BMRN 8-day exponential moving average is 71.36, which is a Buy signal.
-
The stock price of BMRN is 71.53 while Biomarin Pharmaceutical 20-day EMA is 70.32, which makes it a Buy.
-
Biomarin Pharmaceutical 50-day exponential moving average is 68.42 while BMRN share price is 71.53, making it a Buy technically.
-
BMRN stock price is 71.53 and Biomarin Pharmaceutical 200-day simple moving average is 72.59, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
-
Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.13 per share, an increase this year of $1.01 per share, and an increase next year of $1.04 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
-
BMRN Moving Average Covergence Divergence (MACD) indicator is 1.31, suggesting Biomarin Pharmaceutical is a Buy
-
Biomarin Pharmaceutical Relative Strength Index (RSI) is 59.02, which suggest Biomarin Pharmaceutical is overbought
-
The Bollinger Bands (25) for Biomarin Pharmaceutical is (67.94 - 72.12), which suggest Biomarin Pharmaceutical is a Buy
-
The Bollinger Bands (100) for Biomarin Pharmaceutical is (63.45 - 69.33), which suggest Biomarin Pharmaceutical is a Buy
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.